IL6 and myocardial infarction: LGE from 1 to 28 days after MI was unchanged in the vehicle group (27.12 ± 4.34% vs. 29.35 ± 5.16%; p = 0.166), whereas there was a trend to reduction in the anti–IL-6-Ab group (25.7 ± 6.99% vs. 16.15 ± 4.21%; p = 0.099) and a significant reduction in the sgp130Fc group (26.4 ± 4.07% vs. 17.98 ± 2.53%; p = 0.0221) (Figures 4D and 4E).